Takeshita H, Sato M, Shiwaku H O, Semba S, Sakurada A, Hoshi M, Hayashi Y, Tagawa Y, Ayabe H, Horii A
Department of Molecular Pathology, Tohoku University School of Medicine, Sendai.
Jpn J Cancer Res. 1999 Sep;90(9):903-8. doi: 10.1111/j.1349-7006.1999.tb00833.x.
DMBT1 (deleted in malignant brain tumors) is a candidate tumor suppressor gene that has been mapped to chromosome 10q25.3-q26.1, a region in which frequent loss of heterozygosity (LOH) has been observed in several human tumors. Since DMBT1 is highly expressed in the lung, we analyzed LOH at the DMBT1 locus and expression of this gene in lung cancer. Thirty-five (53%) of 66 primary lung cancers showed LOH, and diminished expression of DMBT1 was observed in 20 (91%) of 22 lung cancer cell lines: three (14%) of them showed loss of expression. We further determined the primary structure of DMBT1 and analyzed genetic alterations in this gene using 23 lung cancer cell lines. Two (9%) of them had homozygous deletion within the gene, and two cell lines had genetic aberrations: one was a rearrangement involving exons 5 and 6, and the other was a missense mutation at codon 52. These results suggest that inactivation of the DMBT1 gene plays an important role in human lung carcinogenesis.
DMBT1(恶性脑肿瘤缺失基因)是一种候选肿瘤抑制基因,已被定位到10q25.3 - q26.1染色体区域,在几种人类肿瘤中已观察到该区域频繁出现杂合性缺失(LOH)。由于DMBT1在肺中高度表达,我们分析了肺癌中DMBT1基因座的杂合性缺失情况以及该基因的表达。66例原发性肺癌中有35例(53%)出现杂合性缺失,在22株肺癌细胞系中有20株(91%)观察到DMBT1表达降低:其中3株(14%)表现为表达缺失。我们进一步确定了DMBT1的一级结构,并使用23株肺癌细胞系分析了该基因的基因改变。其中2株(9%)在基因内发生纯合缺失,2株细胞系存在基因畸变:1株是涉及外显子5和6的重排,另1株是密码子52处的错义突变。这些结果表明,DMBT1基因的失活在人类肺癌发生中起重要作用。